Review



recombinant human bromodomain-containing protein 9 (brd9)  (Active Motif)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Active Motif recombinant human bromodomain-containing protein 9 (brd9)
    Recombinant Human Bromodomain Containing Protein 9 (Brd9), supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human bromodomain-containing protein 9 (brd9)/product/Active Motif
    Average 90 stars, based on 1 article reviews
    recombinant human bromodomain-containing protein 9 (brd9) - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    92
    MedChemExpress brd9 protein variants
    Brd9 Protein Variants, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brd9 protein variants/product/MedChemExpress
    Average 92 stars, based on 1 article reviews
    brd9 protein variants - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    90
    Thermo Fisher gst- brd9- bd- 3mut recombinant proteins
    Gst Brd9 Bd 3mut Recombinant Proteins, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gst- brd9- bd- 3mut recombinant proteins/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    gst- brd9- bd- 3mut recombinant proteins - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Active Motif recombinant human bromodomain-containing protein 9 (brd9)
    Recombinant Human Bromodomain Containing Protein 9 (Brd9), supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human bromodomain-containing protein 9 (brd9)/product/Active Motif
    Average 90 stars, based on 1 article reviews
    recombinant human bromodomain-containing protein 9 (brd9) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    C4 Therapeutics brd9 protein degradation compounds
    Notable Molecular Glue-Related Patents
    Brd9 Protein Degradation Compounds, supplied by C4 Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brd9 protein degradation compounds/product/C4 Therapeutics
    Average 90 stars, based on 1 article reviews
    brd9 protein degradation compounds - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    C4 Therapeutics brd9 protein
    Notable Molecular Glue-Related Patents
    Brd9 Protein, supplied by C4 Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brd9 protein/product/C4 Therapeutics
    Average 90 stars, based on 1 article reviews
    brd9 protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Active Motif brd9 protein
    Notable Molecular Glue-Related Patents
    Brd9 Protein, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brd9 protein/product/Active Motif
    Average 90 stars, based on 1 article reviews
    brd9 protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    Bethyl proteins
    Notable Molecular Glue-Related Patents
    Proteins, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteins/product/Bethyl
    Average 94 stars, based on 1 article reviews
    proteins - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Human Protein Atlas brd9 protein
    Identification of <t>BRD9</t> as a potential therapeutic target for cancer treatment. a Expression levels of BRD9 mRNA in nine cancer types in which BRD9 was focally amplified. Gray: normal controls; white: tumors without BRD9 amplification; red: tumors with BRD9 amplification. BRD9 copy number status in each tumor specimen was estimated by a GISTIC analysis. b Expression of BRD9 protein was retrieved from the Human Protein Atlas dataset. A typical immunohistochemical staining of each cancer type is presented. Scale bar indicates 100 μm. c The heatmap of the genes that were significantly, positively co-expressed with BRD9 in nine cancer types. Each tumor is represented in a column and each gene in a row. The RNA expression of BRD9 is presented as a bar graph under the heatmap. The genes were arranged from top to bottom in descending order of their correlation with BRD9 . d The pathways over-represented for BRD9 -associated genes at the pan-cancer and individual cancer levels, according to pre-ranked gene-set enrichment analysis. e The functional hubs of pathways associated with BRD9 expression as analyzed by pre-ranked gene set enrichment. f BRD9 was knocked down with two independent shRNAs in four different breast and ovarian cancer cell lines. Knockdown efficiency was confirmed by real-time RT-PCR. g Four-day growth curves of cancer cell lines transfected with control or BRD9 -specific shRNAs. h , i Soft agar assays of MDA-MB-231 ( h ) and OVCAR8 ( i ) cells expressing control and BRD9 -specific hairpins. Scale bar indicates 1 cm. Quantification of the number of colonies from the soft agar assays on MDA-MB-231 ( h ) and OVCAR8 ( i ) cells. j In vivo xenograft tumor growth curve of MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. k Representative pictures of tumors derived from control and BRD9 -specific hairpin-expressing cells. Scale bar indicates 1 cm. l In vivo tumor weight curves for MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. m Knockdown efficiency of xenograft tumors was confirmed by real-time RT-PCR. * t -test p -value < 0.05
    Brd9 Protein, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brd9 protein/product/Human Protein Atlas
    Average 90 stars, based on 1 article reviews
    brd9 protein - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Notable Molecular Glue-Related Patents

    Journal: Biochemistry

    Article Title: Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic

    doi: 10.1021/acs.biochem.2c00245

    Figure Lengend Snippet: Notable Molecular Glue-Related Patents

    Article Snippet: WO 2021/178920 , compounds for targeted degradation of BRD9 , C4 Therapeutics , BRD9 protein degradation compounds provided for treatment of disorders mediated by BRD9, including abnormal cellular proliferation.

    Techniques: Binding Assay, Ubiquitin Proteomics, Synthesized, Modification, Protein Binding, Activity Assay

    Identification of BRD9 as a potential therapeutic target for cancer treatment. a Expression levels of BRD9 mRNA in nine cancer types in which BRD9 was focally amplified. Gray: normal controls; white: tumors without BRD9 amplification; red: tumors with BRD9 amplification. BRD9 copy number status in each tumor specimen was estimated by a GISTIC analysis. b Expression of BRD9 protein was retrieved from the Human Protein Atlas dataset. A typical immunohistochemical staining of each cancer type is presented. Scale bar indicates 100 μm. c The heatmap of the genes that were significantly, positively co-expressed with BRD9 in nine cancer types. Each tumor is represented in a column and each gene in a row. The RNA expression of BRD9 is presented as a bar graph under the heatmap. The genes were arranged from top to bottom in descending order of their correlation with BRD9 . d The pathways over-represented for BRD9 -associated genes at the pan-cancer and individual cancer levels, according to pre-ranked gene-set enrichment analysis. e The functional hubs of pathways associated with BRD9 expression as analyzed by pre-ranked gene set enrichment. f BRD9 was knocked down with two independent shRNAs in four different breast and ovarian cancer cell lines. Knockdown efficiency was confirmed by real-time RT-PCR. g Four-day growth curves of cancer cell lines transfected with control or BRD9 -specific shRNAs. h , i Soft agar assays of MDA-MB-231 ( h ) and OVCAR8 ( i ) cells expressing control and BRD9 -specific hairpins. Scale bar indicates 1 cm. Quantification of the number of colonies from the soft agar assays on MDA-MB-231 ( h ) and OVCAR8 ( i ) cells. j In vivo xenograft tumor growth curve of MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. k Representative pictures of tumors derived from control and BRD9 -specific hairpin-expressing cells. Scale bar indicates 1 cm. l In vivo tumor weight curves for MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. m Knockdown efficiency of xenograft tumors was confirmed by real-time RT-PCR. * t -test p -value < 0.05

    Journal: Nature Communications

    Article Title: Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment

    doi: 10.1038/s41467-019-08554-x

    Figure Lengend Snippet: Identification of BRD9 as a potential therapeutic target for cancer treatment. a Expression levels of BRD9 mRNA in nine cancer types in which BRD9 was focally amplified. Gray: normal controls; white: tumors without BRD9 amplification; red: tumors with BRD9 amplification. BRD9 copy number status in each tumor specimen was estimated by a GISTIC analysis. b Expression of BRD9 protein was retrieved from the Human Protein Atlas dataset. A typical immunohistochemical staining of each cancer type is presented. Scale bar indicates 100 μm. c The heatmap of the genes that were significantly, positively co-expressed with BRD9 in nine cancer types. Each tumor is represented in a column and each gene in a row. The RNA expression of BRD9 is presented as a bar graph under the heatmap. The genes were arranged from top to bottom in descending order of their correlation with BRD9 . d The pathways over-represented for BRD9 -associated genes at the pan-cancer and individual cancer levels, according to pre-ranked gene-set enrichment analysis. e The functional hubs of pathways associated with BRD9 expression as analyzed by pre-ranked gene set enrichment. f BRD9 was knocked down with two independent shRNAs in four different breast and ovarian cancer cell lines. Knockdown efficiency was confirmed by real-time RT-PCR. g Four-day growth curves of cancer cell lines transfected with control or BRD9 -specific shRNAs. h , i Soft agar assays of MDA-MB-231 ( h ) and OVCAR8 ( i ) cells expressing control and BRD9 -specific hairpins. Scale bar indicates 1 cm. Quantification of the number of colonies from the soft agar assays on MDA-MB-231 ( h ) and OVCAR8 ( i ) cells. j In vivo xenograft tumor growth curve of MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. k Representative pictures of tumors derived from control and BRD9 -specific hairpin-expressing cells. Scale bar indicates 1 cm. l In vivo tumor weight curves for MDA-MB-231 (upper) and OVCAR8 (lower) cells expressing control and BRD9 -specific hairpins. m Knockdown efficiency of xenograft tumors was confirmed by real-time RT-PCR. * t -test p -value < 0.05

    Article Snippet: BRD9 copy number status in each tumor specimen was estimated by a GISTIC analysis. b Expression of BRD9 protein was retrieved from the Human Protein Atlas dataset.

    Techniques: Expressing, Amplification, Immunohistochemical staining, Staining, RNA Expression, Functional Assay, Knockdown, Quantitative RT-PCR, Transfection, Control, In Vivo, Derivative Assay